Suven Pharmaceuticals informs about earnings call transcript

02 Jun 2023 Evaluate
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Pharmaceuticals has informed that it enclosed the transcript of the earnings conference call for the quarter and year ended March 31, 2023 conducted after the meeting of Board of Directors held on May 25, 2023. The above information has been uploaded on the Company's website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release 

The above information is a part of company’s filings submitted to BSE.

Suven Pharma Share Price

1186.45 2.15 (0.18%)
16-Apr-2025 13:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1689.60
Dr. Reddys Lab 1152.65
Cipla 1494.90
Lupin 1948.90
Zydus Lifesciences 843.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...